{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T23:04:26Z","timestamp":1775775866877,"version":"3.50.1"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Iodine is a crucial trace element for the human body and the basic raw material for the synthesis of thyroid hormones. Oral inorganic iodine includes dietary iodine and therapeutic iodine, both of which are closely associated with thyroid immunity and metabolism. Graves\u2019 disease (GD), also known as diffuse toxic goiter, is characterized by hyperthyroidism and high iodine metabolism. Clinically, patients diagnosed with GD are often asked to limit iodine intake or even avoid iodine in their diet. The latest research has demonstrated that the interference of dietary iodine with antithyroid drugs (ATDs) treatment may be overestimated. In addition, as a medication for GD treatment, the administration of inorganic iodine has shown positive results in patients with mild hyperthyroidism, a low thyroid autoantibody concentration, a small thyroid volume, a high iodine diet and so on. Inorganic iodine may also be used as an alternative when patients experience side effects with traditional ATDs and for those who still prefer conservative treatment. Due to its low teratogenicity, blood toxicity and bone marrow toxicity, inorganic iodine plays a unique role in special populations, such as pregnant or lactating patients and patients receiving tumor radiotherapy or chemotherapy. In this review, the research progress, biological function, doses and effects, applicable populations and specific applications of dietary iodine and therapeutic iodine are summarized to provide references for the diagnosis and treatment of GD, thus improving the quality of life of GD patients.<\/jats:p>","DOI":"10.3389\/fendo.2023.1150036","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T05:12:39Z","timestamp":1680498759000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Application of oral inorganic iodine in the treatment of Graves\u2019 disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Yixuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"B1","article-title":"Treatment with inorganic iodine for graves' hyperthyroidism","volume":"64","author":"Noh","year":"2006","journal-title":"Nihon Rinsho"},{"key":"B2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/1872214811666170608120810","article-title":"Iodine prophylaxis in the lights of the last recommendation of WHO on reduction of daily salt intake","volume":"11","author":"Zbigniew","year":"2017","journal-title":"Recent Pat Endocr Metab Immune Drug Discovery"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00859-4","article-title":"Effect of lugol's solution on 131I therapy efficacy in graves' disease","author":"Chai","year":"2022","journal-title":"Clin Exp Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101388","article-title":"Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy","volume":"34","author":"Antonelli","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0392","article-title":"Characteristics of patients with graves' disease whose thyroid hormone levels increase after substituting potassium iodide for methimazole in the first trimester of pregnancy","volume":"30","author":"Yoshihara","year":"2020","journal-title":"Thyroid"},{"key":"B6","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.amjsurg.2016.11.048","article-title":"Preparation of graves' disease patients for surgery - role of inorganic iodides","volume":"214","author":"Gaurav","year":"2017","journal-title":"Am J Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/09553002.2021.1987570","article-title":"Modeling principles of protective thyroid blocking","volume":"98","author":"Rump","year":"2022","journal-title":"Int J Radiat Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1212044","article-title":"Kinetics of acute and chronic iodine excess","volume":"106","author":"Saller","year":"1998","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-62703-697-9_9","article-title":"Thyrotoxic crisis: Thyroid storm","author":"Reyes-Castano","year":"2014","journal-title":"Endocrine Emergencies"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-020-0417-5","article-title":"Allosteric regulation of mammalian Na+\/I- symporter activity by perchlorate","volume":"27","author":"Llorente-Esteban","year":"2020","journal-title":"Nat Struct Mol Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.723750","article-title":"Monocarboxylate transporter 8 deficiency: From pathophysiological understanding to therapy development","volume":"12","author":"van Geest","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9090884","article-title":"The transcriptomic response of the murine thyroid gland to iodide overload and the role of the Nrf2 antioxidant system","volume":"9","author":"Chartoumpekis","year":"2020","journal-title":"Antioxid (Basel)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0566","article-title":"Re-visiting autoimmunity to sodium-iodide symporter and pendrin in thyroid disease","volume":"183","author":"Eleftheriadou","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0171","article-title":"GLOBAL ENDOCRINOLOGY. global perspectives in endocrinology: Coverage of iodized salt programs and iodine status in 2020","volume":"185","author":"Zimmermann","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.651534","article-title":"Hyperthyroidism prevalence in China after universal salt iodization","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0261-z","article-title":"Salt iodization halves risk of thyrotoxicosis in Denmark","volume":"15","author":"Zimmermann","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0975","article-title":"Effect of the transition from more than adequate iodine to adequate iodine on national changes in the prevalence of thyroid disorders: Repeat national cross-sectional surveys in China","volume":"186","author":"Li","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0067","article-title":"Efficacy and safety of long-term universal salt iodization on thyroid disorders: Epidemiological evidence from 31 provinces of mainland China","volume":"30","author":"Li","year":"2020","journal-title":"Thyroid"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054022","article-title":"Effect of iodine intake on thyroid diseases in China","volume":"354","author":"Teng","year":"2006","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0613","article-title":"Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: A cross-sectional study in 10 cities","volume":"26","author":"Shan","year":"2016","journal-title":"Thyroid"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0212","article-title":"U-Shaped relationship between iodine status and thyroid autoimmunity risk in adults","volume":"181","author":"Wang","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2174\/1871530315666150619094242","article-title":"Selenium and iodine in autoimmune thyroiditis","volume":"15","author":"Guastamacchia","year":"2015","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s10653-017-9985-7","article-title":"Medical geology of endemic goiter in kalutara, Sri lanka; distribution and possible causes","volume":"39","author":"Fernando","year":"2017","journal-title":"Environ Geochem Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1089\/thy.2016.0635","article-title":"Multiple nutritional factors and the risk of hashimoto's thyroiditis","volume":"27","author":"Hu","year":"2017","journal-title":"Thyroid"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01736","article-title":"Double-blind, placebo-controlled, randomized trial of selenium in graves hyperthyroidism","volume":"102","author":"Kahaly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2021.1070","article-title":"Antithyroid drug treatment in graves' disease","volume":"36","author":"Chung","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1954","article-title":"Comparative effectiveness of therapies for graves' hyperthyroidism: A systematic review and network meta-analysis","volume":"98","author":"Sundaresh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/nu13124469","article-title":"Iodine: Its role in thyroid hormone biosynthesis and beyond","volume":"13","author":"Sorrenti","year":"2021","journal-title":"Nutrients"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13543","article-title":"Optimal iodine supplementation during antithyroid drug therapy for graves' disease is associated with lower recurrence rates than iodine restriction","volume":"88","author":"Huang","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1210\/jc.2013-4466","article-title":"Remission after potassium iodide therapy in patients with graves' hyperthyroidism exhibiting thionamide-associated side effects","volume":"99","author":"Okamura","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-30-4-469","article-title":"Effect of iodide on thyroidal iodine turnover in hyperthyroid subjects","volume":"30","author":"Nagataki","year":"1970","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ19-0379","article-title":"Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with graves' disease","volume":"67","author":"Suzuki","year":"2020","journal-title":"Endocr J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1160\/nukmed-0045","article-title":"Administration of additional inactive iodide during radioiodine therapy for graves' disease: Who might benefit","volume":"46","author":"Dietlein","year":"2007","journal-title":"Nuklearmedizin"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.6411-20","article-title":"Clinical studies on potassium iodide-induced painless thyroiditis in 11 graves' disease patients","volume":"60","author":"Kamijo","year":"2021","journal-title":"Intern Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0581","article-title":"Substituting potassium iodide for methimazole as the treatment for graves' disease during the first trimester may reduce the incidence of congenital anomalies: A retrospective study at a single medical institution in Japan","volume":"25","author":"Yoshihara","year":"2015","journal-title":"Thyroid"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-021-03032-2","article-title":"Study on the effect of different iodine intake on hippocampal metabolism in offspring rats","volume":"200","author":"Zhang","year":"2022","journal-title":"Biol Trace Elem Res"},{"key":"B38","article-title":"The importance of iodine nutrition during pregnancy - clinical aspect","volume":"160","author":"\u017dabkov\u00e1","year":"2021","journal-title":"Cas Lek Cesk"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa187","article-title":"Thyroid function of infants breastfed by mothers with graves disease treated with inorganic iodine: A study of 100 cases","volume":"5","author":"Hamada","year":"2020","journal-title":"J Endocr Soc"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.666207","article-title":"Thyroid function in Preterm\/Low birth weight infants: Impact on diagnosis and management of thyroid dysfunction","volume":"12","author":"LaFranchi","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B41","article-title":"Iodine status in premature newborns","volume":"160","author":"Ibrahim","year":"2021","journal-title":"Cas Lek Cesk"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2221","article-title":"Antithyroid drug-induced hematopoietic damage: A retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with graves' disease","volume":"97","author":"Watanabe","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ20-0016","article-title":"Clinical experience of treating graves' hyperthyroidism complicated with malignancy-the possible role of potassium iodide for avoiding the risk of thionamide-associated neutropenia","volume":"67","author":"Okamura","year":"2020","journal-title":"Endocr J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-015-0281-z","article-title":"Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy","volume":"38","author":"Gianetti","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0182","article-title":"Antithyroid drug use in pregnancy and birth defects: Why some studies find clear associations, and some studies report none","volume":"25","author":"Laurberg","year":"2015","journal-title":"Thyroid"},{"key":"B46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.toxlet.2021.10.010","article-title":"Perinatal exposure to the thyroperoxidase inhibitors methimazole and amitrole perturbs thyroid hormone system signaling and alters motor activity in rat offspring","volume":"354","author":"Ramh\u00f8j","year":"2022","journal-title":"Toxicol Lett"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01399-y","article-title":"The role of placental iodine storage in the neonatal thyroid stimulating hormone surge: Iodine as a driving force to adapt the terrestrial life","volume":"44","author":"Karaoglan","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-021-03050-0","article-title":"What iodine intervention measures should be taken in different water iodine areas? evidence from a cross-sectional Chinese survey","volume":"200","author":"Du","year":"2022","journal-title":"Biol Trace Elem Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid association guideline for the management of graves' hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"B51","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1210\/endrev\/bnab029","article-title":"The role of iodine for thyroid function in lactating women and infants","volume":"43","author":"Andersson","year":"2022","journal-title":"Endocr Rev"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-1320","article-title":"Prevalence and course of thyroid dysfunction in neonates at high risk of graves' disease or with non-autoimmune hyperthyroidism","volume":"184","author":"Benlarbi","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.endien.2021.11.005","article-title":"Follow-up of infants born to mothers with graves' disease","volume":"68","author":"Maximiano","year":"2021","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11882","article-title":"Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management","volume":"100","author":"Crawford","year":"2004","journal-title":"Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2021.04.023","article-title":"Effect of preoperative potassium iodide administration on graves' disease surgery: A propensity score analysis","volume":"222","author":"Barranquero","year":"2021","journal-title":"Am J Surg"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-020-05593-0","article-title":"Preoperative potassium iodide treatment in patients undergoing thyroidectomy for graves' disease-perspective of a European high-volume center","volume":"44","author":"Lindner","year":"2020","journal-title":"World J Surg"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0126","article-title":"Influence of short-term dietary and therapeutic iodine restriction on the therapeutic effects of radioactive iodine therapy in patients with graves' disease","volume":"31","author":"Nishio","year":"2021","journal-title":"Thyroid"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256727","article-title":"Effect of TSH stimulation protocols on adequacy of low-iodine diet for radioiodine administration","volume":"16","author":"Lee","year":"2021","journal-title":"PloS One"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.22088\/cjim.12.0.371","article-title":"Graves' disease treated by complementary medicine leading to thyroid storm: A case report","volume":"12","author":"Daffini","year":"2021","journal-title":"Caspian J Intern Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-019-05125-5","article-title":"Outcomes after urgent thyroidectomy following rapid control of thyrotoxicosis in graves' disease are similar to those after elective surgery in well-controlled disease","volume":"43","author":"Ali","year":"2019","journal-title":"World J Surg"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15854","article-title":"Potassium iodide tablets instead of a saturated solution preoperatively for reaching euthyroidism quickly in refractory graves' disease","volume":"13","author":"Chiapponi","year":"2021","journal-title":"Cureus"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2020.05.029","article-title":"Coronary artery spasm-induced cardiac arrest precipitated by iodine contrast load in unknown pre-existing graves' disease","volume":"13","author":"Dhami","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"B63","volume-title":"Jod basedow syndrome","author":"Rose","year":"2022"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1150036\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T05:12:45Z","timestamp":1680498765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1150036\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":63,"alternative-id":["10.3389\/fendo.2023.1150036"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1150036","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"article-number":"1150036"}}